Stay updated on FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check7 days agoChange DetectedA new site revision label appears: Revision: v3.6.4 replaces the previous v3.6.3 in the page footer. This indicates a minor platform update and does not affect the study information presented.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page revision indicator was updated to v3.6.3, replacing the previous v3.6.2. This signals a small update to the page's documentation/versioning without changing the study details or visible content.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page now shows a new revision label in the footer, indicating an update to the page version without altering the displayed study details or layout.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page adds sections for How to Read a Study Record, Common Questions, and How to Join a Study and presents recruitment status as 'No longer looking for participants,' while the Intervention/Treatment heading formatting is adjusted and the revision label updated from v3.5.5 to v3.6.0.SummaryDifference0.9%

- Check57 days agoChange DetectedThe page revision has been updated from v3.5.4 to v3.5.5, indicating a backend or display update. It does not modify the study content or user-facing functionality beyond metadata.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating an internal update to the study record page. There is no indication that substantive study details were changed.SummaryDifference0.1%

Stay in the know with updates to FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.